EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR-222-3p loaded stem cell nanovesicles repair myocardial ischemia damage via inhibiting mitochondrial oxidative stress

Mei Liu, Le Wang, Zhao Liu, Dongyue Liu, Tianshuo Li, Lini Ding, Shasha Zeng, Zi Wang, Jiaqiu Wang, Fan Zhang, Jun Zhang, Limin Zhang und 4 weitere

Life Sciences · 2025

DOI: 10.1016/j.lfs.2025.123447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2025. Verfasst von Mei Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, the First Hospital of HeBei Medical University, Shijiazhuang 050031, Hebei Province, China; Hebei Provincial K…. Hauptthemen laut MEDLINE: MicroRNAs, Oxidative Stress, Myocardial Reperfusion Injury, Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Science and Technology Support Program, National Natural Science Foundation of China, Hebei Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Mitochondrial oxidative stress (MOS) is a key contributor to poor cardiac function and a major driver of myocardial ischemia-reperfusion injury (MIRI). Our previous research demonstrated that stem cell-derived nanovesicles (NVs) enhanced cardiac function following ischemia-reperfusion (I/R) injury, although the underlying mechanisms remain unclear. We constructed and characterized miR-222-3p-loaded NVs. MATERIALS AND METHODS: An in vitro hypoxia-reoxygenation (H/R) model was established using H9C2 cardiomyocytes. Mitochondrial oxidative respiratory function was assessed using Seahorse XF technology, while mitochondrial reactive oxygen species (mtROS) levels were quantified via flow cytometry. Additional assessments included mitochondrial permeability transition pore (mPTP) status, mitochondrial membrane potential, and mitochondrial DNA (mtDNA) integrity. An in vivo H/R model was developed using C57BL/6 mice. The therapeutic effects of NVs on MOS reduction and cardiac function improvement were evaluated through Masson's staining, immunofluorescence, echocardiography, transmission electron microscopy (TEM), and positron emission tomography/computed tomography (PET/CT). KEY FINDINGS: RNA immunoprecipitation (RIP) confirmed that miR-222-3p directly targets cyp1a1. Overexpression of miR-222-3p or knockdown of cyp1a1 significantly improved mitochondrial activity in cardiomyocytes and conferred protection against I/R injury. Conversely, overexpression of cyp1a1 abrogated the protective effects of miR-222-3p. In vivo, NV treatment enhanced cardiac function, reduced MOS, and improved mitochondrial respiratory capacity in MIRI model mice. NV treatment, via miR-222-3p-mediated suppression of cyp1a1, mitigates MOS, enhances mitochondrial respiratory function, and improves cardiac outcomes in MIRI models. SIGNIFICANCE: These findings provide a foundational basis for the clinical translation of NV-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOxidative StressMyocardial Reperfusion InjuryStem CellsMitochondriaMyocardial IschemiaAnimalsMice, Inbred C57BLMiceMyocytes, CardiacMaleRatsReactive Oxygen SpeciesCell LineMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

Cyp1a1Ischemia reperfusionMiR-222-3pMyocardial injury repairNanovesiclesReactive oxygen species

Substanzen

MicroRNAsMIRN222 microRNA, mouseReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, the First Hospital of HeBei Medical University, Shijiazhuang 050031, Hebei Province, China; Hebei Provincial Key Laboratory of Cardiac Injury Repair Mechanism Study, Shijiazhuang 0…
  • Department of Cardiovascular Medicine, the First Hospital of HeBei Medical University, Shijiazhuang 050031, Hebei Province, China; Hebei Provincial Key Laboratory of Heart and Metabolism, Shijiazhuang 050031, Hebei Prov…
  • Traditional Chinese Medicine Processing Technology Innovation Center of Hebei Province, School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050091, China; The First Affilfated Hospital of Hebei Univer…
  • Stem Cell Regenerative Medicine Clinical Research Center, the First Hospital of HeBei Medical University, Shijiazhuang 050031, Hebei Province, China.
  • Department of Epidemiology and Health Statistics, School of Public Health, Hebei Medical University, Hebei Key Laboratory of Environment and Human Health, Shijiazhuang 050017, China.
  • College of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, China.

Förderung

  • Hebei Province Science and Technology Support Program
  • National Natural Science Foundation of China
  • Hebei Provincial Natural Science Foundation

Zitieren

APA

Liu, M., Wang, L., Liu, Z., Liu, D., Li, T., Ding, L., Zeng, S., Wang, Z., Wang, J., Zhang, F., Zhang, J., Zhang, L., Li, M., Liu, G., Wang, X., & Zheng, M. (2025). MiR-222-3p loaded stem cell nanovesicles repair myocardial ischemia damage via inhibiting mitochondrial oxidative stress. Life Sciences. https://doi.org/10.1016/j.lfs.2025.123447

Vancouver

Liu M, Wang L, Liu Z, Liu D, Li T, Ding L, et al. MiR-222-3p loaded stem cell nanovesicles repair myocardial ischemia damage via inhibiting mitochondrial oxidative stress. Life Sciences. 2025. doi:10.1016/j.lfs.2025.123447

BibTeX
@article{Liu2025,
  author = {Liu, Mei and Wang, Le and Liu, Zhao and Liu, Dongyue and Li, Tianshuo and Ding, Lini and Zeng, Shasha and Wang, Zi and Wang, Jiaqiu and Zhang, Fan and Zhang, Jun and Zhang, Limin and Li, Meng and Liu, Gang and Wang, Xianyun and Zheng, Mingqi},
  title = {MiR-222-3p loaded stem cell nanovesicles repair myocardial ischemia damage via inhibiting mitochondrial oxidative stress},
  journal = {Life Sciences},
  year = {2025},
  doi = {10.1016/j.lfs.2025.123447}
}
Kostenlos starten →